Suppr超能文献

RPR112378和RPR115781:微管组装抑制剂新家族的两个代表。

RPR112378 and RPR115781: two representatives of a new family of microtubule assembly inhibitors.

作者信息

Combeau C, Provost J, Lancelin F, Tournoux Y, Prod'homme F, Herman F, Lavelle F, Leboul J, Vuilhorgne M

机构信息

Rhône-Poulenc Rorer S.A., Centre de Recherche de Vitry-Alfortville, Vitry-Sur-Seine, France.

出版信息

Mol Pharmacol. 2000 Mar;57(3):553-63. doi: 10.1124/mol.57.3.553.

Abstract

A screening program aimed at the discovery of new antimicrotubule agents yielded RPR112378 and RPR115781, two natural compounds extracted from the Indian plant Ottelia alismoides. We report their isolation, structural determination, and mechanisms of action. RPR112378 is an efficient inhibitor of tubulin polymerization (IC(50) = 1.2 microM) and is able to disassemble preformed microtubules. Regarding tubulin activity, RPR115781 is 5-fold less active than RPR112378. Tubulin-RPR112378 complexes, when isolated by gel filtration, were able to block further tubulin addition to growing microtubules, a mechanism that accounts for the substoichiometric effect of the drug. RPR112378 was found to prevent colchicine binding but not vinblastine binding to tubulin. Although colchicine binding is known to induce an increase of tubulin GTPase activity, no such increase was observed with RPR112378. We show that RPR112378 is a highly cytotoxic compound and that RPR115781 is 10, 000-fold less active as an inhibitor of KB cell growth. Part of the cytotoxicity of RPR112378 is probably caused by a reaction of addition with sulfhydryl groups, an observation that has not been made with RPR115781. In conclusion, these molecules represent a new class of inhibitors of microtubule assembly with potential therapeutic value.

摘要

一项旨在发现新型抗微管药物的筛选计划得到了RPR112378和RPR115781,这两种天然化合物是从印度植物水车前中提取的。我们报告了它们的分离、结构测定及作用机制。RPR112378是微管蛋白聚合的有效抑制剂(IC(50)=1.2 microM),并且能够拆解预先形成的微管。关于微管蛋白活性,RPR115781的活性比RPR112378低5倍。通过凝胶过滤分离得到的微管蛋白-RPR112378复合物能够阻止微管蛋白进一步添加到正在生长的微管上,这一机制解释了该药物的亚化学计量效应。发现RPR112378可阻止秋水仙碱与微管蛋白结合,但不能阻止长春碱与微管蛋白结合。虽然已知秋水仙碱结合会诱导微管蛋白GTP酶活性增加,但RPR112378并未观察到这种增加。我们表明RPR112378是一种高细胞毒性化合物,而RPR115781作为KB细胞生长抑制剂的活性低10000倍。RPR112378的部分细胞毒性可能是由与巯基的加成反应引起的,而RPR115781未观察到这一现象。总之,这些分子代表了一类具有潜在治疗价值的新型微管组装抑制剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验